Prestige BioPharma Commences Construction of Innovative Discovery Center (IDC) in Busan, Korea

Excerpt Prestige BioPharma Limited a Singapore-based biopharmaceutical with operations in USA and South Korea, commences construction of Innovative Discovery Center (IDC) in Busan, South Korea. The construction of IDC is scheduled for completion by February 2023. Article Summary PBP holds a ceremony with Korean government officials and guests including Deputy Mayor of Busan City Mr. […]

Samsung Biologics to Construct New Manufacturing Facility for Next-Gen Vaccines and CGT

Excerpt Samsung Biologics is planning to construct a new manufacturing facility in Incheon, South Korea. This new facility will offer multi-product manufacturing, including cell and gene therapies and next-gen vaccines. Article Summary Samsung Biologics announced that it plans to start building a new facility, plant 5, this year at Songdo in Incheon, South Korea. The […]

Tower launches System for the Transport of Ultra Cold Temperature-critical Pharmaceuticals


Pharmaceutical thermal protection provider, Tower Cold Chain, launched its latest system, the KTM42D Tower Double Euro Pallet Ultra Cold, which is a fully reusable double-pallet temperature-controlled packaging container for the transportation and extended storage of products that require an internal temperature range of -80˚C to -60˚C. It is intended for the transportation of vaccines, life […]

German Cold Chain and Biopharma Logistics Firm Hit by Cyber Attack


Billion-dollar logistics firm Hellmann Worldwide Logistics reported a cyberattack this week that forced them to temporarily remove all connections to their central data center. The company said the shut down was having a “material impact” on their business operations.  The German company operates in 173 countries, running logistics for a range of air and sea […]

Thermo Fisher Scientific Completes Acquisition of PPD, Inc.


Thermo Fisher Scientific Inc., the world leader in serving science announced that it has completed its acquisition of PPD, Inc., a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion. Marc N. Casper, Chairman, President and Chief Executive Officer of Thermo Fisher Scientific said, “We are very excited […]

WuXi Completed First GMP Production at New 24,000L Line of MFG5 Facility


WuXi Biologics, a global company with leading open-access biologics technology platforms has recently announced that the first GMP production at the new 24,000L line of its drug substance facility MFG5 has successfully completed. This new line in addition to the 36,000L biomanufacturing line of MFD5 makes the total production capacity to 60,000L. MFG5 aims to […]

I-MAB Biopharma and AGC Biologics Partner on Late-Phase Project


AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced a new partnership with I-MAB Biopharma. AGC Biologics will manufacture the materials of I-MAB treatment at its site in Seattle, while also supporting the launch readiness of I-MAB’s product. The Seattle cell culture facility is designed for capacity and technological flexibility, and […]

Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy


Samsung Biologics and AstraZeneca continues their strategic biopharmaceutical manufacturing collaboration to manufacturer AstraZeneca’s COVID-19 long-acting antibody (LAAB) combination, AZD7442, and will start to manufacture a cancer immunotherapy product from next year following an expanded deal this year in May 2021. With additional treatments manufactured, the value of the agreement boosted to approximately $380 million up […]

Korean Logistics Provider Kukbo Enters Strategic Agreement with Redhill Biopharma


Excerpt: RedHill Biopharma Ltd, a specialty biopharmaceutical company, today announced that it has entered into a strategic agreement with Kukbo Co. Ltd, a South Korean corporation, for the sale of RedHill’s American Depositary Shares (“ADSs”) in a private placement of up to $10 million at a 20% premium to the prior 30 trading days’ volume […]

WuXi Biologics Launches a New GMP Commercial Drug Product Facility


Excerpt: WuXi Biologics, a leading global open-access biologics technology platform offering end-to-end biologics development solutions has launched a GMP operation of the new drug product facility at Wuxi, China. The eighth operational drug facility is called DP2 with 12,000 m² and features an isolator filling line for continuous high speed production of biologics drugs. The […]

Baxter Announces $100 Million Investment in BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility


Excerpt Baxter International Inc., a global leader in sterile medication production and delivery announced a ~$100 million investment in the sterile fill/finish manufacturing facility located in Halle/Westfalen, Germany. A business unit of Baxter, BioPharma Solutions (BPS) which specializes in development and contract manufacturing of drug products for parenteral (injectable) pharmaceuticals partnering with pharmaceutical and biotech […]

Lonza to Expand Microbial Development Laboratories


Excerpt: Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, announced additional microbial development capabilities in Switzerland. The investment, expected to be used by the end of 2021, supports increased capacity of development services targeting microbial-derived proteins with expanded laboratory space and equipment. The extension aims to support new projects in Lonza’s […]